Bluesky Facebook Reddit Email

Durability of protection against symptomatic COVID-19 in vaccine trial participants

06.08.22 | JAMA Network

Rigol DP832 Triple-Output Bench Power Supply

Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.

About The Study: Researchers assessed the durability of protection against symptomatic COVID-19 among participants of the Moderna vaccine trial.

Authors: Dan-Yu Lin, Ph.D., of the University of North Carolina, Chapel Hill, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2022.15984)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.15984?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=060822

About JAMA Network Open : JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Keywords

Article Information

Contact Information

JAMA Network Media Relations
JAMA Network
mediarelations@jamanetwork.org

How to Cite This Article

APA:
JAMA Network. (2022, June 8). Durability of protection against symptomatic COVID-19 in vaccine trial participants. Brightsurf News. https://www.brightsurf.com/news/12DY3MO1/durability-of-protection-against-symptomatic-covid-19-in-vaccine-trial-participants.html
MLA:
"Durability of protection against symptomatic COVID-19 in vaccine trial participants." Brightsurf News, Jun. 8 2022, https://www.brightsurf.com/news/12DY3MO1/durability-of-protection-against-symptomatic-covid-19-in-vaccine-trial-participants.html.